Evidence map›Paper›PMID 39807359›Full record

ArticleCurrent research in food science2025

A pectic polysaccharide from

Dai Dong, Hailiang Wang, Hongtao Bi, Yu Li, Tingting Gao, Jingyue Feng, Guoqiang Li, Shiqi Guo, Hongyan Yuan, Weihua Ni

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Current research in food science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Topical MongolianJournal of clinical biochemistry and nutrition · 2026
    Article
  2. Review
  3. Structural-activity relationship ofFrontiers in immunology · 2026
    Review
  4. Review
  5. Nutrients · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Dai DongDepartment of Immunology, College of Basic Medical Sciences, Jilin University, 126 Xin min Street, Changchun, 130021, China.
Hailiang WangThe Second Hospital of Jilin University, 218 Ziqiang Street, Changchun, 130033, China.
Hongtao BiQinghai Provincial Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, CAS, 23 Xinning Road, Xining, 810008, China.
Yu LiDepartment of Immunology, College of Basic Medical Sciences, Jilin University, 126 Xin min Street, Changchun, 130021, China.
Tingting GaoSchool of Psychology, Chengdu Medical College, 783 Xindu Road, Chengdu, 610500, China.
Jingyue FengDepartment of Immunology, College of Basic Medical Sciences, Jilin University, 126 Xin min Street, Changchun, 130021, China.
Guoqiang LiQinghai Provincial Key Laboratory of Tibetan Medicine Pharmacology and Safety Evaluation, Northwest Institute of Plateau Biology, CAS, 23 Xinning Road, Xining, 810008, China.
Shiqi GuoThe Second Hospital of Jilin University, 218 Ziqiang Street, Changchun, 130033, China.
Hongyan YuanDepartment of Immunology, College of Basic Medical Sciences, Jilin University, 126 Xin min Street, Changchun, 130021, China.
Weihua NiDepartment of Immunology, College of Basic Medical Sciences, Jilin University, 126 Xin min Street, Changchun, 130021, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory bowel disorders (IBD) can lead to severe complications like perforation, bleeding, and colon cancer, posing life-threatening risks.

Indexed as

ColitisGut microbiotaIntestinal barrierIntestinal immune homeostasisLycium ruthenicum murr.Polysaccharide

Identifiers

PMID39807359
PMCPMC11728900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.